Published in Biochem J on October 01, 1999
A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol Pain (2010) 1.05
Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding. Br J Pharmacol (2004) 0.95
Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J (2001) 0.95
Organization and expression of the SLC36 cluster of amino acid transporter genes. Mamm Genome (2004) 0.94
The roles played by highly truncated splice variants of G protein-coupled receptors. J Mol Signal (2012) 0.92
G protein-coupled receptors: walking hand-in-hand, talking hand-in-hand? Br J Pharmacol (2011) 0.86
Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction. J Urol (2005) 0.85
Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management. Mayo Clin Proc (2015) 0.81
Differential modulation of α-1 adrenoceptor subtypes by antidepressants in the rat brain. J Neural Transm (Vienna) (2010) 0.78
Molecular characterization and analysis of a truncated serotonin receptor gene expressed in neural and reproductive tissues of abalone. Histochem Cell Biol (2009) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol (1988) 12.84
A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem (1996) 3.77
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev (1995) 2.53
alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res (1996) 1.90
The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Mol Pharmacol (1994) 1.71
Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol (1997) 1.53
Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor. Biochem Biophys Res Commun (1993) 1.25
Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry (1998) 1.21
Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol (1996) 1.15
Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2. J Biol Chem (1992) 1.15
Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype. Br J Pharmacol (1995) 1.15
Genomic organization and expression of the human alpha 1B-adrenergic receptor. J Biol Chem (1992) 1.14
Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. Biochem J (1998) 1.12
Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c. Biochem Biophys Res Commun (1994) 1.12
Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol Endocrinol (1997) 1.11
Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J (1996) 1.10
Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc Natl Acad Sci U S A (1993) 1.03
Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol (1997) 1.03
Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem (1997) 1.01
Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants. FEBS Lett (1995) 1.01
Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms. FEBS Lett (1998) 0.97
Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs. J Mol Cell Cardiol (1998) 0.91
Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia. J Neurosci (1996) 0.90
On the origin of mRNA encoding the truncated dopamine D3-type receptor D3nf and detection of D3nf-like immunoreactivity in human brain. J Biol Chem (1994) 0.89
Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor. Pflugers Arch (1994) 0.89
Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J Biol Chem (1995) 0.85
The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types. Br J Pharmacol (1995) 0.84
No role for Ca++ or protein kinase C in alpha-1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells. Mol Pharmacol (1999) 0.83
Transcriptional regulation of the human alpha1a-adrenergic receptor gene. Characterization Of the 5'-regulatory and promoter region. J Biol Chem (1997) 0.80
Semiquantitative evaluation of alpha1A-adrenoceptor subtype mRNA in human hypertrophied and non-hypertrophied prostates: regional comparison. Life Sci (1999) 0.78
Flow cytometry analysis of alpha1-adrenoceptor subtypes. FEBS Lett (1996) 0.77
The CD40 antigen and its ligand. Annu Rev Immunol (1994) 7.26
A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab (2000) 2.33
Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost (2015) 2.05
A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J Gen Virol (1992) 1.77
IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol (1993) 1.62
Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem (2000) 1.59
Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett (1997) 1.52
Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes. J Biol Chem (1986) 1.47
Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol (1996) 1.46
[Free radicals and HIV infection]. Ann Biol Clin (Paris) (1998) 1.43
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol (2008) 1.42
Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med (1993) 1.42
B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol (1994) 1.41
Kidney biopsy in the critically ill patient, results of a multicentre retrospective case series. Minerva Anestesiol (2012) 1.40
Diagnostic contribution from pulmonary biopsies in hematology patients with acute respiratory failure from undetermined etiology. Minerva Anestesiol (2013) 1.39
Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein. J Virol (1994) 1.39
Response of newborn lambs to CO-induced hypoxia. J Appl Physiol (1985) (1988) 1.38
Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay K8644) and inhibitor (PN 200-110). Proc Natl Acad Sci U S A (1986) 1.33
Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization. J Pharmacol Exp Ther (2001) 1.28
Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett (1998) 1.21
Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia (2005) 1.15
Regulation of calcium channels in aortic muscle cells by protein kinase C activators (diacylglycerol and phorbol esters) and by peptides (vasopressin and bombesin) that stimulate phosphoinositide breakdown. J Biol Chem (1987) 1.14
IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol (1993) 1.12
Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-binding switch in melatonin synthesis. Proc Natl Acad Sci U S A (2001) 1.12
Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery. Br J Pharmacol (1996) 1.09
Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science (2007) 1.08
High affinity binding of human interleukin 4 to cell lines. Biochem Biophys Res Commun (1987) 1.06
Paradoxical inward rib cage motion during rapid eye movement sleep in infants and young children. J Dev Physiol (1987) 1.05
Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J Neuroendocrinol (2001) 1.04
Structure and expression of the human histamine H4-receptor gene. Biochem Biophys Res Commun (2001) 1.04
Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1998) 1.03
Comparison of the adherence of three Lactobacillus strains to Caco-2 and Int-407 human intestinal cell lines. Lett Appl Microbiol (1996) 1.01
Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species. Br J Pharmacol (1994) 1.01
Substrate specificity and inhibition studies of human serotonin N-acetyltransferase. J Biol Chem (2000) 1.00
Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur J Immunol (1993) 1.00
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J Neurosci (2000) 1.00
Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 . Biochem Pharmacol (2001) 1.00
The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis (2002) 0.99
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. Biochem Biophys Res Commun (2005) 0.98
Thyroarytenoid muscle activity during hypoxia in awake lambs. J Appl Physiol (1985) (1990) 0.98
Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation. Eur J Immunol (1990) 0.97
Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol (1997) 0.97
Obesity is associated with decreasing levels of the circulating soluble leptin receptor in humans. Int J Obes Relat Metab Disord (2002) 0.96
Cloning and characterization of the 5' flanking region of the human uncoupling protein 3 (UCP3) gene. Biochem Biophys Res Commun (1999) 0.95
Evaluation of 13 selected medicinal plants from Burkina Faso for their antiplasmodial properties. J Ethnopharmacol (2010) 0.95
Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J (2001) 0.95
Characterisation of cyclooxygenase 1 and 2 expression in mouse resident peritoneal macrophages in vitro; interactions of non steroidal anti-inflammatory drugs with COX2. Biochim Biophys Acta (1995) 0.95
The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor. Br J Pharmacol (2009) 0.95
Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors. Proc Natl Acad Sci U S A (1986) 0.94
High-performance liquid chromatographic separation and dual competitive binding assay of corrinoids in biological material. J Chromatogr (1990) 0.94
S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther (2000) 0.93
[3H] verapamil binding sites in skeletal muscle transverse tubule membranes. Biochem Biophys Res Commun (1984) 0.93
A combined 1H perfusion/3He ventilation NMR study in rat lungs. Magn Reson Med (1999) 0.92
Resistance to high-fat-diet-induced obesity and sexual dimorphism in the metabolic responses of transgenic mice with moderate uncoupling protein 3 overexpression in glycolytic skeletal muscles. Diabetologia (2007) 0.92
The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr (2000) 0.91
Structural elements of secretory phospholipases A2 involved in the binding to M-type receptors. J Biol Chem (1995) 0.91
Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands. Eur J Pharmacol (2001) 0.90
Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Mol Pharmacol (2001) 0.89
Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses. Vaccine (1995) 0.89
Therapeutic perspectives for melatonin agonists and antagonists. J Neuroendocrinol (2003) 0.89
Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide. Br J Pharmacol (1996) 0.89
IgE levels in intestinal juice. Dig Dis Sci (1980) 0.89
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors. J Med Chem (2000) 0.88